Dr. Castro will be speaking on “Epigenetic reprogramming of the DNA repair machinery and hematopoiesis in mutant IDH1 gliomas” on April 8, 2024 in Portland.
Dr. Pedro Lowenstein Speaking at University of Michigan BIBC Challenge Event
Dear Research Colleagues, We invite you to join us for the “Bioengineering in Brain Cancer ” Challenge, co-hosted by the BioInnovations in Brain Cancer Program and the Biointerfaces Institute on January 19th – 20th, 2024, at the North Campus Research Complex (NCRC). The goal of this 2-day challenge is to bring together clinicians, scientists, and engineers to explore new ideas and catalyze interdisciplinary collaborative research to address the challenges…
Dr. Maria Castro Speaking at Penn State University FEBRUARY 14, 4:00 PM TO 5:00 PM
BMS Seminar Series: Maria Castro, PhD FEBRUARY 14, 4:00 PM TO 5:00 PM Maria Castro, PhD, R.C. Schneider Collegiate Professor of Neurosurgery and professor of cell and developmental biology at University of Michigan Medical School, will be presenting a research talk as part of the Biomedical Sciences Seminar Series. For more information, email Jessica Kirkwood at jlk296@psu.edu.
Bioinnovations in Brain Cancer Challenge Event
BIBC Challenge Event DATE: Friday, January 19, 2024—Saturday, January 20, 2024 TIME: 8:00 am—3:00 pm LOCATION: NCRC Dining Hall the BioInnovations in Brain Cancer Program in partnership with the Biointerfaces Institute will be hosting “Bioengineering in Brain Cancer” Challenge, on January 19th – 20th, 2024, at the North Campus Research Complex (NCRC). This is an event for UM faculty, clinicians and senior researchers to explore new ideas and catalyze…
Registration now opens for Translational Research Cancer Centers Consortium Annual Meeting
Registration-Read more here Agenda-Read more here
Congratulations to the Lab Members who will be presenting posters at SNO Conference
Please check out the posters at the SNO conference Thursday November 16th-Sunday November 19th, 2023. Dr. Pedro Lowenstein/Anna Argento-“Brain tumors: from oncostreams to active liquid crystals”. Dr. Andrea Comba- “Targeting tumor-associated Smooth Muscle Actin (ACTA2) expression in mouse pre-clinical glioma models reduces tumor progression and extends survival”. Brandon McClellan-“Mutant isocitrate dehydrogenase 1 in glioma causes a reduction in adenosinergic pathway signaling within the tumor microenvironment”.…
Dr. Maria Luisa Varela will be speaking at SNO Conference
Dr. Varela will be speaking Thursday November 16th, 2023 at the BTIIC mini-symposium. Dr. Varela will be speaking on Collagen receptor LAIR-1 regulates glioma microenvironment and tumor progression at 2:10pm
Dr. Maria Castro speaking at SNO conference.
Dr. Castro will be speaking on Saturday November 18, 2023 at the “The Tumor Microenvironment and Immune Regulation” special session. She will be speaking at 7:15am on “Epigenetic Reprogramming of the Immune Microenvironment in Gliomas: Therapeutic implications”.
Human Genetics Seminar Series-Presenting Dr. Pedro Lowenstein
“Gene Therapy for Brain Tumors: from brain/immune co-evolution to a novel therapy in humans” Presented by:Pedro Lowenstein, M.D., Ph.D.Richard C. Schneider Collegiate Professor of NeurosurgeryProfessor, Department of NeurosurgeryProfessor, Department of Cell and Developmental BiologyUniversity of Michigan Medical School Monday, October 2311:00 AM – 12:00 PM ESTBSRB – 1020 Kahn Auditorium Hosted by:Jordan Shavit, M.D., Ph.D.Professor of PediatricsProfessor of Human GeneticsHenry and Mala Dorfman Family Professor of Pediatric Hematology/OncologyUniversity…
Press releases for “H3.3-G34 mutations impair DNA repair and promote cGAS/STING-mediated immune responses in pediatric high-grade glioma models” cover publication.
News Medical Life Sciences Verve Times News AZI Technology Networks Medical Press Science Daily Mirage EurekAlert! Bioengineer.org ScienMag Sciencenewsnet newswise